Back
Artelo Biosciences, Inc. 10K Form
Sell
35
ARTL
Artelo Biosciences, Inc.
Last Price:
$1.91
Seasonality Move:
12.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARTL News And Ratings
See the #1 stock for the next 7 days that we like better than ARTL
ARTL Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-3.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.41 |
| Price / Book: | 10.94 |
Profitability
| EPS (TTM): | -17.29700 |
|---|---|
| Net Income (TTM): | $-12.5M |
| Gross Margin: | $0 |
| Return on Equity: | -797.54% |
| Return on Assets: | -260.52% |
Artelo Biosciences, Inc. Earnings Forecast
Key Artelo Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 11 years have been positive in 3 years.
Artelo Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | ARTL |
| Website: | artelobio.com |
Debt
| Debt-to-Equity Ratio: | -1.51 |
|---|---|
| Current Ratio: | 0.38 |
| Quick Ratio: | 0.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ARTL Technical Analysis vs Fundamental Analysis
Sell
35
Artelo Biosciences, Inc. (ARTL)
is a Sell
Is Artelo Biosciences, Inc. a Buy or a Sell?
-
Artelo Biosciences, Inc. stock is rated a SellThe current Artelo Biosciences, Inc. [ARTL] share price is $1.94. The Score for ARTL is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.